Townsend Adam J. (CIK 0001773588)

Latest company ownership

APLS - Apellis Pharmaceuticals, Inc.
Role: Chief Commercial Officer
Shares held
84,050
Last filed at
Jan 30, 2025
Confidence Score
49.7
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2025 Jan 30, 2025 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 48.8 -695 -0.82% ✗ $20.5K
Jan 22, 2025 Jan 23, 2025 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 42.5 -3,323 -3.77% ✗ $101.1K
Jan 17, 2025 Jan 21, 2025 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 42.5 -2,201 -2.44% ✗ $65.9K
Jan 13, 2025 Jan 14, 2025 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 42.5 -2,685 -2.89% ✗ $77.1K
Feb 12, 2024 Feb 13, 2024 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 42.5 -1,148 -1.23% ✗ $77.8K
Jan 29, 2024 Jan 31, 2024 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 45.0 -906 -0.96% ✗ $58.1K
Jan 22, 2024 Jan 23, 2024 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 42.5 -3,413 -3.49% ✗ $221.8K
Jan 16, 2024 Jan 17, 2024 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 95.0 +21,513 28.16% ✗ $149.3K
Dec 1, 2023 Dec 5, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 3.8 -110,000 -59.01% ✓ $6.7M
May 3, 2023 May 4, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 30.0 -5,000 -6.17% ✓ $413.6K
Apr 3, 2023 Apr 5, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 30.0 -5,000 -6.17% ✓ $370.3K
Mar 3, 2023 Mar 7, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 30.0 -5,000 -6.17% ✓ $319.2K
Feb 21, 2023 Feb 22, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 95.0 +8,845 13.17% ✗ $60.9K
Feb 10, 2023 Feb 14, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 26.3 -782 -1.15% ✗ $40K
Feb 3, 2023 Feb 6, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 30.0 -5,000 -6.86% ✓ $279.3K
Jan 27, 2023 Jan 30, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 36.3 -551 -0.80% ✗ $29.1K
Jan 20, 2023 Jan 24, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -1,912 -2.72% ✗ $99.5K
Jan 3, 2023 Jan 5, 2023 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -10.44% ✓ $253.5K
Dec 5, 2022 Dec 7, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -10.44% ✓ $251.9K
Nov 3, 2022 Nov 7, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -10.44% ✓ $292.7K
Oct 3, 2022 Oct 5, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -10.44% ✓ $333.5K
Sep 6, 2022 Sep 7, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -10.44% ✓ $301.9K
Aug 15, 2022 Aug 16, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 12.5 -12,500 -22.56% ✓ $862.5K
Aug 11, 2022 Aug 12, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 12.5 -12,500 -22.56% ✓ $837.5K
Aug 8, 2022 Aug 9, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 12.5 -12,500 -22.56% ✓ $812.5K
Aug 3, 2022 Aug 4, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 22.5 -5,000 -11.65% ✓ $282.2K
Apr 21, 2022 Jul 12, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 32.5 -6,875 -7.48% ✓ $242.1K
Feb 10, 2022 Feb 14, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 46.3 -895 -1.99% ✗ $42.2K
Jan 28, 2022 Feb 1, 2022 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 46.3 -800 -1.75% ✗ $30.9K
Feb 10, 2021 Feb 11, 2021 Apellis Pharmaceuticals, Inc. Chief Commercial Officer Sell 26.3 -688 -3.52% ✗ $32.8K